Cargando…

Oxymatrine Protects TGFβ1-Induced Retinal Fibrosis in an Animal Model of Glaucoma

Glaucoma has engulfed a huge population of the world into its claws of blindness as it remains asymptomatic until nearly 40% of the neurons are lost and the only option left is for patients to be subjected to symptomatic treatments or surgical methods, neither of which is completely effective in cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Ashmita, Kashyap, Onkar, Singh, Amrita, Shree, Jaya, Namdeo, Kamta P., Bodakhe, Surendra H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894676/
https://www.ncbi.nlm.nih.gov/pubmed/35252223
http://dx.doi.org/10.3389/fmed.2021.750342
_version_ 1784662733555236864
author Das, Ashmita
Kashyap, Onkar
Singh, Amrita
Shree, Jaya
Namdeo, Kamta P.
Bodakhe, Surendra H.
author_facet Das, Ashmita
Kashyap, Onkar
Singh, Amrita
Shree, Jaya
Namdeo, Kamta P.
Bodakhe, Surendra H.
author_sort Das, Ashmita
collection PubMed
description Glaucoma has engulfed a huge population of the world into its claws of blindness as it remains asymptomatic until nearly 40% of the neurons are lost and the only option left is for patients to be subjected to symptomatic treatments or surgical methods, neither of which is completely effective in curing the disease as they do not restore the physiological dimensions at the neuronal level. Among the several factors that drive the pathophysiology of glaucoma, one is the involvement of fibrogenic factors, such as transforming growth factor β (TGFβ) which remodels the extracellular matrix (ECM) and, thus, the deposition of fibrotic material in the retina, resulting in the progression of primary open-angle glaucoma (POAG). The primary objectives of this study were to evaluate the protective effects of oxymatrine (OMT) in the steroid-induced glaucoma model in experimental rats and to determine the role of transforming growth factor β1 (TGFβ1) in the pathogenesis of glaucoma and its consequent inhibition due to the antioxidant and the antiinflammatory, and also the TGFβ1 antagonistic, behavior of OMT. To that end, we experimentally elucidated the role of OMT, a TGFβ1 antagonist, that is known to play antiinflammatory and antioxidant roles in the steroid-induced glaucoma model in experimental rats, and using the enzyme-linked immunosorbent assay (ELISA), we observed a direct inhibitory effect of OMT on the pathogenesis of glaucoma. The antioxidant and the antiinflammatory potentials of OMT were determined using several biochemical methods to determine the major antioxidants in the retinal layers, such as superoxide dismutase (SOD), glutathione peroxidase (GP(X)), catalase (CAT), and glutathione (GSH), along with the nitrite and the malondialdehyde (MDA) concentration levels. As a result, OMT was found to reduce the total protein content in the retinal layers, a correlation that has not been previously reported. Moreover, the impacts of OMT on the major governing ATPases, namely Na(+)/K(+) ATPase and Ca(2+)ATPase, along with its impacts on the intracellular ionic concentrations of Na(+), K(+), and Ca(2+), were determined and were found to point toward OMT, restoring homeostasis in glaucomatous animals. A clearer picture of the changes during the treatment was obtained using retinal images of the live animals and of the lenticular changes in the sacrificed animal; these images provided data on the pathological pathways leading to glaucoma inception and its consequent inhibition by OMT. The data reported in this study clearly indicate that OMT has a possible role in inhibiting the pathogenesis of glaucoma, and the data also permit the quantification of several biochemical parameters of concern.
format Online
Article
Text
id pubmed-8894676
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88946762022-03-05 Oxymatrine Protects TGFβ1-Induced Retinal Fibrosis in an Animal Model of Glaucoma Das, Ashmita Kashyap, Onkar Singh, Amrita Shree, Jaya Namdeo, Kamta P. Bodakhe, Surendra H. Front Med (Lausanne) Medicine Glaucoma has engulfed a huge population of the world into its claws of blindness as it remains asymptomatic until nearly 40% of the neurons are lost and the only option left is for patients to be subjected to symptomatic treatments or surgical methods, neither of which is completely effective in curing the disease as they do not restore the physiological dimensions at the neuronal level. Among the several factors that drive the pathophysiology of glaucoma, one is the involvement of fibrogenic factors, such as transforming growth factor β (TGFβ) which remodels the extracellular matrix (ECM) and, thus, the deposition of fibrotic material in the retina, resulting in the progression of primary open-angle glaucoma (POAG). The primary objectives of this study were to evaluate the protective effects of oxymatrine (OMT) in the steroid-induced glaucoma model in experimental rats and to determine the role of transforming growth factor β1 (TGFβ1) in the pathogenesis of glaucoma and its consequent inhibition due to the antioxidant and the antiinflammatory, and also the TGFβ1 antagonistic, behavior of OMT. To that end, we experimentally elucidated the role of OMT, a TGFβ1 antagonist, that is known to play antiinflammatory and antioxidant roles in the steroid-induced glaucoma model in experimental rats, and using the enzyme-linked immunosorbent assay (ELISA), we observed a direct inhibitory effect of OMT on the pathogenesis of glaucoma. The antioxidant and the antiinflammatory potentials of OMT were determined using several biochemical methods to determine the major antioxidants in the retinal layers, such as superoxide dismutase (SOD), glutathione peroxidase (GP(X)), catalase (CAT), and glutathione (GSH), along with the nitrite and the malondialdehyde (MDA) concentration levels. As a result, OMT was found to reduce the total protein content in the retinal layers, a correlation that has not been previously reported. Moreover, the impacts of OMT on the major governing ATPases, namely Na(+)/K(+) ATPase and Ca(2+)ATPase, along with its impacts on the intracellular ionic concentrations of Na(+), K(+), and Ca(2+), were determined and were found to point toward OMT, restoring homeostasis in glaucomatous animals. A clearer picture of the changes during the treatment was obtained using retinal images of the live animals and of the lenticular changes in the sacrificed animal; these images provided data on the pathological pathways leading to glaucoma inception and its consequent inhibition by OMT. The data reported in this study clearly indicate that OMT has a possible role in inhibiting the pathogenesis of glaucoma, and the data also permit the quantification of several biochemical parameters of concern. Frontiers Media S.A. 2022-02-18 /pmc/articles/PMC8894676/ /pubmed/35252223 http://dx.doi.org/10.3389/fmed.2021.750342 Text en Copyright © 2022 Das, Kashyap, Singh, Shree, Namdeo and Bodakhe. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Das, Ashmita
Kashyap, Onkar
Singh, Amrita
Shree, Jaya
Namdeo, Kamta P.
Bodakhe, Surendra H.
Oxymatrine Protects TGFβ1-Induced Retinal Fibrosis in an Animal Model of Glaucoma
title Oxymatrine Protects TGFβ1-Induced Retinal Fibrosis in an Animal Model of Glaucoma
title_full Oxymatrine Protects TGFβ1-Induced Retinal Fibrosis in an Animal Model of Glaucoma
title_fullStr Oxymatrine Protects TGFβ1-Induced Retinal Fibrosis in an Animal Model of Glaucoma
title_full_unstemmed Oxymatrine Protects TGFβ1-Induced Retinal Fibrosis in an Animal Model of Glaucoma
title_short Oxymatrine Protects TGFβ1-Induced Retinal Fibrosis in an Animal Model of Glaucoma
title_sort oxymatrine protects tgfβ1-induced retinal fibrosis in an animal model of glaucoma
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894676/
https://www.ncbi.nlm.nih.gov/pubmed/35252223
http://dx.doi.org/10.3389/fmed.2021.750342
work_keys_str_mv AT dasashmita oxymatrineprotectstgfb1inducedretinalfibrosisinananimalmodelofglaucoma
AT kashyaponkar oxymatrineprotectstgfb1inducedretinalfibrosisinananimalmodelofglaucoma
AT singhamrita oxymatrineprotectstgfb1inducedretinalfibrosisinananimalmodelofglaucoma
AT shreejaya oxymatrineprotectstgfb1inducedretinalfibrosisinananimalmodelofglaucoma
AT namdeokamtap oxymatrineprotectstgfb1inducedretinalfibrosisinananimalmodelofglaucoma
AT bodakhesurendrah oxymatrineprotectstgfb1inducedretinalfibrosisinananimalmodelofglaucoma